Beneficial Effects of Akkermansia muciniphila Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists
Open Access
- 19 January 2021
- Vol. 10 (1), 185
- https://doi.org/10.3390/cells10010185
Abstract
Akkermansia muciniphila is considered as one of the next-generation beneficial bacteria in the context of obesity and associated metabolic disorders. Although a first proof-of-concept of its beneficial effects has been established in the context of metabolic syndrome in humans, mechanisms are not yet fully understood. This study aimed at deciphering whether the bacterium exerts its beneficial properties through the modulation of the endocannabinoidome (eCBome). Circulating levels of 25 endogenous endocannabinoid-related lipids were quantified by liquid chromatography with tandem mass spectrometry (LC-MS/MS) in the plasma of overweight or obese individuals before and after a 3 months intervention consisting of the daily ingestion of either alive or pasteurized A. muciniphila. Results from multivariate analyses suggested that the beneficial effects of A. muciniphila were not linked to an overall modification of the eCBome. However, subsequent univariate analysis showed that the decrease in 1-Palmitoyl-glycerol (1-PG) and 2-Palmitoyl-glycerol (2-PG), two eCBome lipids, observed in the placebo group was significantly counteracted by the alive bacterium, and to a lower extent by the pasteurized form. We also discovered that 1- and 2-PG are endogenous activators of peroxisome proliferator-activated receptor alpha (PPARα). We hypothesize that PPARα activation by mono-palmitoyl-glycerols may underlie part of the beneficial metabolic effects induced by A. muciniphila in human metabolic syndrome.Keywords
Funding Information
- Canada Excellence Research Chairs, Government of Canada (Gut Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND))
This publication has 78 references indexed in Scilit:
- Function of Akkermansia muciniphila in Obesity: Interactions With Lipid Metabolism, Immune Response and Gut SystemsFrontiers in Microbiology, 2020
- Human gut microbiome: hopes, threats and promisesGut, 2018
- Gut Microbes and Health: A Focus on the Mechanisms Linking Microbes, Obesity, and Related DisordersObesity, 2018
- Gut microbiota and obesity: Concepts relevant to clinical careEuropean Journal of Internal Medicine, 2018
- Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphilaFrontiers in Microbiology, 2017
- Akkermansia muciniphila and its role in regulating host functionsMicrobial Pathogenesis, 2017
- TriggeringAkkermansiawith dietary polyphenols: A new weapon to combat the metabolic syndrome?Gut Microbes, 2016
- Talking microbes: When gut bacteria interact with diet and host organsMolecular Nutrition & Food Research, 2015
- Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesityProceedings of the National Academy of Sciences of the United States of America, 2013
- Microbes inside—from diversity to function: the case of AkkermansiaThe ISME Journal, 2012